Cover Image

Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007.

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Interstate Commerce, Trade, and Tourism (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 2013.
Series:	S. hrg. ; 110-1189
Subjects:	Drugs > Purchasing > United States. Drugs > Prices > United States. Prescription pricing > United States. Pharmaceutical industry > United States. Drug reimportation > Government policy > United States. Internet pharmacies > Government policy > United States. Consumer protection > United States. Foreign trade regulation > United States. Pharmaceutical policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/gpo33763 http://purl.fdlp.gov/GPO/gpo33763

Similar Items

Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005.
Published: (2005)

Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005.
Published: (2005)

Drug importation : the realities of safety and security : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the realities of safety and security regarding drug importation, February 16, 2005.
Published: (2005)

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.
Published: (2004)

Prescription drug reimportation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, first session, November 20, 2003.
Published: (2016)

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.
Published: (2019)

Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B drug discount program, March 15, 2018.
Published: (2020)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019.
Published: (2022)

Options for safe and effective prescription drug importation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, March 11, 2004.
Published: (2012)

Prescription drugs : enhanced efforts and better agency coordination needed to address illegal importation : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives /
by: Stana, Richard M.
Published: (2005)

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.
Published: (2004)

Administrative Procedure Act challenges to CMS's implementation of the Medicare Drug Price Negotiation Program /
by: Rogers, Hannah-Alise
Published: (2024)

Implementation of the Medicare Drug Price Negotiation Program : Centers for Medicare and Medicaid guidance and legal considerations /
by: Rogers, Hannah-Alise
Published: (2023)

Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.
Published: (2022)

Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers [as printed] : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, September 5, 2001.
Published: (2003)

The complex web of prescription drug prices : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC.
Published: (2022)

Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019.
Published: (2020)

The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019.
Published: (2022)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

Examining the implications of drug importation : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, July 14, 2004.
Published: (2008)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act /
by: Adams, Christopher P., et al.
Published: (2021)

Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019.
Published: (2019)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011.
Published: (2014)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Would prescription drug importation reduce U.S. drug spending.
by: Baker, Colin (Colin Sean)
Published: (2007)

Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021.
Published: (2022)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Studies in pharmaceutical economics /
Published: (1996)

Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019" : scheduled for markup by the House Committee on Ways and Means on October 22, 2019 /
Published: (2019)

Report on prescription drug importation /
Published: (2004)

Examining the proposed Medicare part B drug demonstration : hearing before the Committee on Finance, United States Senate, One Hundred Fourteenth Congress, second session, June 28, 2016.
Published: (2017)

The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018.
Published: (2020)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.
Published: (2003)

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.
Published: (2003)